Odyssey HealthODYY +2.86% Return-on-Tangible-Asset is 559.63% as of Apr. 2026. The stock has 4 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Odyssey Health ranks worse than 99.65% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Odyssey Health's annualizedNet Income for the quarter that ended in Apr. 2026 was $3.06 Mil. Odyssey Health's average total tangible assets for the quarter that ended in Apr. 2026 was $0.55 Mil. Therefore, Odyssey Health's annualized Return-on-Tangible-Asset for the quarter that ended in Apr. 2026 was 559.63%.
The historical rank and industry rank for Odyssey Health's Return-on-Tangible-Asset or its related term are showing as below:
ODYY'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -8959.46 Med: -1017.74 Max: -169.76
Current: -1227.99
During the past 11 years, Odyssey Health's highest Return-on-Tangible-Asset was -169.76%. The lowest was -8959.46%. And the median was -1017.74%.
ODYY's Return-on-Tangible-Asset is ranked worse than 99.65% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.57
vs ODYY: -1227.99
Odyssey Health (OTCPK:ODYY) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Odyssey Health Return-on-Tangible-Asset Related Terms
Odyssey Health Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Odyssey Health's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ODYY vs SSKN, NUMD, PFSA: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Odyssey Health's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Odyssey Health Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Odyssey Health's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Apr. 2026) net income data.
What does a Return-on-Tangible-Asset of 559.63% mean?
Odyssey Health (ODYY) has a Return-on-Tangible-Asset of 559.63% as of Apr. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Odyssey Health and its competitors. According to the industry distribution chart, Odyssey Health ranks #854 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 99.6%.
Is Odyssey Health's Return-on-Tangible-Asset too high?
Odyssey Health's current Return-on-Tangible-Asset is 559.63%. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.57. Odyssey Health's value of 559.63% is 98080.7% above this industry median. Based on the distribution chart, Odyssey Health ranks #854 out of 857 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Odyssey Health's Return-on-Tangible-Asset compare to SSKN and NUMD?
According to the Medical Devices & Instruments industry distribution chart, Odyssey Health ranks #854 out of 857 companies for Return-on-Tangible-Asset. This places Odyssey Health in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.57. Odyssey Health's value of 559.63% is 98080.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.57, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Odyssey Health's current Return-on-Tangible-Asset of 559.63% is 98080.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Odyssey Health and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Odyssey Health's current Return-on-Tangible-Asset is 559.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Odyssey Health stock overvalued right now?
Odyssey Health (ODYY) has a current Return-on-Tangible-Asset of 559.63%. The current Return-on-Tangible-Asset is 559.63% and 98080.7% above the Medical Devices & Instruments industry median of 0.57. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Odyssey Health (ODYY), the current Return-on-Tangible-Asset is 559.63% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ODYY has been successfully added to your 